Technical Analysis for VGEN - Vaccinogen Inc

Grade Last Price % Change Price Change
grade F 0.0001 0.00% 0.0000
VGEN closed unchanged on Friday, March 8, 2019, on 1.41 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical VGEN trend table...

Date Alert Name Type % Chg
Expansion Breakdown Bearish Swing Setup 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%

Older signals for VGEN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vaccinogen, Inc. is a biotechnology company. The Company is the developer of OncoVAX. OncoVAX is an active specific immunotherapy (ASI) that uses the patient's own cancer cells to create a vaccine that in turn is used to block the return of cancer following surgery. OncoVAX is a patient specific immunotherapy for stage II colon cancer and its technology may have application in other tumor types, such as melanoma and renal cell carcinoma. The OncoVAX patient-specific vaccine consists of sterile, metabolically active, irradiated and non-tumorigenic autologous cancer cells, with or without fresh frozen Bacillus Calmette-Guerin (BCG) bacteria as an adjuvant. The Company has completed a Phase IIIa study of OncoVAX.
Medicine Health Biotechnology RTT Cancer Surgery Immunotherapy Tumor Cancer Treatments Vaccination Melanoma Vaccine Cancer Vaccines Biotechnology Companies Renal Cell Carcinoma
Is VGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 1.88
52 Week Low 0.0001
Average Volume 7,092
200-Day Moving Average 0.3331
50-Day Moving Average 0.0614
20-Day Moving Average 0.0001
10-Day Moving Average 0.0001
Average True Range 0.0037
ADX 5.9
+DI 49.8134
-DI 49.8134
Chandelier Exit (Long, 3 ATRs ) -0.0109
Chandelier Exit (Short, 3 ATRs ) 0.0112
Upper Bollinger Band 0.0002
Lower Bollinger Band 0.0
Percent B (%b) 0.5
BandWidth 200.0
MACD Line -0.0152
MACD Signal Line -0.0198
MACD Histogram 0.0045
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0001
Resistance 3 (R3) 0.0001 0.0001 0.0001
Resistance 2 (R2) 0.0001 0.0001 0.0001 0.0001
Resistance 1 (R1) 0.0001 0.0001 0.0001 0.0001 0.0001
Pivot Point 0.0001 0.0001 0.0001 0.0001 0.0001
Support 1 (S1) 0.0001 0.0001 0.0001 0.0001 0.0001
Support 2 (S2) 0.0001 0.0001 0.0001 0.0001
Support 3 (S3) 0.0001 0.0001 0.0001
Support 4 (S4) 0.0001